Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Contraception - Management
What types of combined oral contraceptives (COCs) are available?

  • Combined oral contraceptives (COCs) consist of two components and these can vary in strength between different preparations (Table 1).
    • Oestrogen component: ethinylestradiol (or a prodrug of ethinylestradiol), a synthetic oestrogen.
    • Progestogen component: one of the following:
      • Levonorgestrel, norethisterone, norethisterone acetate (metabolized to norethisterone), or norgestimate (metabolized to levonorgestrel).
      • Desogestrel or gestodene.
      • Drospirenone (a derivative of spironolactone). This has anti-androgenic properties and anti-mineralocorticoid activity (unlike most other progestogens).
  • COC preparations can be categorized according to:
    • The dose/strength of oestrogen:
      • Low-strength COCs contain 20 micrograms of ethinylestradiol.
      • Standard-strength preparations contain 30–35 micrograms of ethinylestradiol in monophasic COCs and 30–40 micrograms ethinylestradiol in phased preparations.
      • Higher-strength preparations with 50 or more micrograms of ethinylestradiol are no longer used.
    • The progestogen component: see above.
    • How the doses vary over the menstrual cycle:
      • Monophasic COCs: the amount of oestrogen and progestogen in each active tablet is constant throughout the cycle.
      • Phasic COCs: the amounts of oestrogen and progestogen vary over the cycle.
      • Biphasic COCs: contain two different sets of tablets.
      • Triphasic COCs: contain three different sets.
    • The presence or absence of a pill-free interval:
      • Products with 21 pills: most COCs are packaged as calendar strips of 21 active tablets. One tablet is taken daily for 3 weeks; no tablet is taken during the following 7 days.
      • Every-day COCs: to aid compliance, some products are packed with 21 active tablets and 7 inert or placebo tablets; a tablet is taken every day of the 28 day cycle.
Table 1. Combined oral contraceptives (COCs) currently marketed in the UK.
Oestrogen
(micrograms per day)
Progestogen
(micrograms per day)
Products
Monophasic combined oral contraceptives
Low strength oestrogen
Ethinylestradiol 20
Norethisterone acetate 1000
Loestrin 20®
Ethinylestradiol 20
Desestrogel 150
Mercilon®, Gedarel® 20/150
Ethinylestradiol 20
Gestodene 75
Femodette®, Sunya®, Milinette® 20/75
30 micrograms oestrogen, first-line progestogen
Ethinylestradiol 30
Norethisterone acetate 1500
Loestrin 30®
Ethinylestradiol 30
Levonorgestrel 150
Microgynon 30®, Microgynon 30 ED®, Ovranette®, Levest®, Rigevidon®
Ethinylestradiol 30
Levonorgestrel 250
Eugynon 30®
35 micrograms oestrogen, first-line progestogen
Ethinylestradiol 35
Norethisterone 500
Brevinor®, Ovysmen®
Ethinylestradiol 35
Norethisterone 1000
Norimin®
Mestranol 50*
Norethisterone 1000
Norinyl-1®
30–35 micrograms oestrogen, second-line progestogen
Ethinylestradiol 30
Desogestrel 150
Marvelon®, Gedarel® 30/150
Ethinylestradiol 30
Gestodene 75
Femodene®, Femodene ED®, Katya®, Millinette® 30/75
Ethinylestradiol 35
Norgestimate 250
Cilest®
Ethinylestradiol 30
Drospirenone 3000
Yasmin®
Primarily therapy for acne
Ethinylestradiol 35
Cyproterone acetate 2000
Generic: co-cyprindiol 2000/35 tablets.
Brand names included: Acnocin®, Cicafem®, Clairette®, Dianette®, Diva®
Biphasic combined oral contraceptives
Ethinylestradiol 35
Norethisterone 500 x 7, 1000 x 14
BiNovum®
Triphasic combined oral contraceptives
Ethinylestradiol 35
Norethisterone 500 x 7, 1000 x 9, 500 x 5
Synphase®
Ethinylestradiol 35
Norethisterone 500 x 7, 750 x 7, 100 x 7
Trinovum®
Ethinylestradiol 30 x 6, 40 x 5, 30 x 10
Levonorgestrel 50 x 6, 75 x 5, 125 x 10
Logynon®, Logynon ED®, Triregol®
Ethinylestradiol 30 x 6, 40 x 5, 30 x 10
Gestodene 50 x 5, 70 x 5, 100 x 10
Triadene®
ED = every day.
* Mestranol is converted in the liver with 70% efficiency to ethinylestradiol; i.e. 50 micrograms of mestranol is pharmacologically equivalent to 35 micrograms of ethinylestradiol.
Data from [BNF 53, 2007]

© NHS Institute for Innovation and Improvement